Numaferm

Combining science with an innovative spirit
Founded in 2017 in Duesseldorf, Germany, Numaferm has become a trusted partner in the field of the recombinant expression of peptides, pepteins and proteins. Our team of ~ 30 experts is built to solve all challenges along the way from discovery to commercialization. With more than 15 Ph. D. level scientists and cumulated relevant experiences of + 100 years, highest scientific expertise is guaranteed. Our facility of 500 m2 (5,300 ft2) is equipped with state-of-the-art technology ensuring industry-grade processes and GMP/commercial production at third party CMOs. Quality and customer satisfaction is of highest importance and we are operating in accordance to the ISO9001:2015 standards. Our technologies and our operations were recognized by national and international media and awarded with prestigious prices.

to left

Chief Executive Officer

Dr. Roland Hecht

CEO

Chief Scientific Officer

Dr. Christian Schwarz

CSO & Co-Founder of Numaferm GmbH

Advisory Board

Dr. Anke Caßing
Dr. Anke Caßing

Senior Investment Manager,
High-Tech-Gründerfonds

Dr. Jens Busse
Dr. Jens Busse

Investment Manager,
Evonik Ventures

Dr. Klaus Binder
Dr. Klaus Binder

CEO & Founder,
Binder Associates

Robert E. W. Hancock
Robert E. W. Hancock

Killam Professor Microbiology / Immunology,
University of British Columbia

Dr. Jürgen Schumacher
Dr. Jürgen Schumacher

Business Angel & Serial Entrepreneur,
i.e. Qiagen and NewLab

Dr. Karl-Heinz Maurer
Dr. Karl-Heinz Maurer

Chairman of the Board,
CLIB

Prof. Dirk Lütkemeyer
Prof. Dirk Lütkemeyer

University of Bielefeld,
Co-founder Bibitec

Prof. em. Dr. Dr. h.c. Detlev Riesner
Prof. em. Dr. Dr. h.c. Detlev Riesner

Business Angel & Serial Entrepreneur,
i.e. Qiagen and Evotec

Prof. Dr. Karl-Erich Jaeger
Prof. Dr. Karl-Erich Jaeger

Forschungszentrum Jülich/HHU,
Co-founder evoxx

Prof. Dr. Lutz Schmitt
Prof. Dr. Lutz Schmitt

Chair Biochemistry I,
Heinrich-Heine-Universität Düsseldorf

Alain Scarso, PhD
Alain Scarso, PhD

Peptide CMO expert,
i.e. Polypeptide and Lonza (retired)

Dr. Christian Schwarz
Dr. Christian Schwarz

CEO and co-founder,
Numaferm GmbH

Our Investors

Join our team

We appreciate your contributions
View Open Positions